Patients With Post-COVID Cognitive Symptoms May Have Gliosis

Medscape - June 15, 2023

Vilma Gabbay, M.D., comments on a study that suggests patients with persistent depressive or cognitive symptoms after COVID-19 may have gliosis, a condition that occurs when the body creates more or larger glial cells, which support nerve cells. Dr. Gabbay is professor of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein and is also the director of the Psychiatry Research Institute at Montefiore Einstein (PRIME) Center for Biomarkers and Dimensional Psychiatry.

Small Number of COVID Patients Develop Severe Psychotic Symptoms

The New York Times - December 28, 2020

Jonathan Alpert, M.D., Ph.D., and Vilma Gabbay, M.D., discuss their published case report on two patients who developed psychosis for the first time after recovering from COVID-19. Dr. Alpert is chair of psychiatry and behavioral sciences at Einstein and Montefiore and Dr. Gabbay is co-director of the Psychiatry Research Institute at Montefiore Einstein.